Levo Therapeutics, Inc. clinical trials
Acquired by ACADIA Pharmaceuticals Inc., Jun 2022 · source ↗
The registry lists 1 studies whose lead sponsor is Levo Therapeutics, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 26, 2022.
Before and after it joined ACADIA Pharmaceuticals Inc.
- First submitted before Levo Therapeutics, Inc. became part of ACADIA Pharmaceuticals Inc.
- 1
- First submitted after Levo Therapeutics, Inc. became part of ACADIA Pharmaceuticals Inc.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Levo Therapeutics, Inc.1 study
Something wrong with this grouping? Tell us on the ACADIA Pharmaceuticals Inc. page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All ACADIA Pharmaceuticals Inc. studies →
- Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi SyndromeCompletedNCT03649477Phase 3
Sponsor listed in the registry: Levo Therapeutics, Inc. · First submitted before Levo Therapeutics, Inc. became part of ACADIA Pharmaceuticals Inc.